From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
January 26, 2021
Philadelphia, PA, January 26, 2021 – IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced a preferred partnership with Datavant, the leader in helping healthcare organizations safely connect their data. IntegriChain will utilize Datavant’s patient de-identification and tokenization solutions to improve the patient-level integration of specialty pharmacy, hub, nurse, co-pay program, lab, and claims data sets.
“Datavant has developed an unrivalled network of data providers that are utilizing its tokenization technology,” said Josh Halpern, IntegriChain co-founder and Executive Vice President. “We’re excited to offer our Life Sciences customers new ways to compliantly and securely integrate their ecosystems of patient-level data assets while also gaining better control over integration quality. Patient mastering is the single most important requirement for aggregation quality, and Datavant gives us new ways to ensure the accuracy of specialty patient journey analytics.”
“We are excited to enter into this partnership with IntegriChain to continue improving patient outcomes and access to specialty drugs,” said Travis May, Founder and Chief Executive Officer of Datavant. “As therapeutics become more and more targeted, having a holistic view of the patient is more challenging but also more important than ever.”
ICyte Patient Products
Patient Data Aggregation utilizes IntegriChain’s industry-leading data science and master data management technology to ensure the accuracy and actionability of patient status data
Refined Patient Data deploys world-class data science and statistical models to monitor, cleanse, and properly map aggregated patient status data, turning a useless mess into actionable data.
Specialty Pharmacy Analytics diagnostic patient access insights by calibrating the datasets associated with a suite of business key performance indicators and analytics to reflect the uniqueness of a brand’s patient journey.
About Datavant Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of de-identified patient records across datasets. Datavant is headquartered in San Francisco. Learn more about Datavant at www.datavant.com.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 250 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services, and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contacts
IntegriChain: Jennifer Guinan, Sage Strategic Marketing, 610.410.8111, Jennifer@sagestrat.com
Datavant | Sarah Rowe, Head of Marketing | pr@datavant.com
Save the date!
Webinars & Resources
See List
